Home Applications 219488 Application 219488
Type NDA
Sponsor MIRUM Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 CTEXLI CHENODIOL TABLET;ORAL 250MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N219488-001 CTEXLI CHENODIOL 250MG TABLET / ORAL RLD, RS 2025-02-21
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N219488-001 NP 2028-02-21 N219488-001 ODE-523 2032-02-21
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N219488-001 CTEXLI 250MG TABLET / ORAL RLD, RS 2025-02-21 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N219488-001 CTEXLI 250MG TABLET / ORAL RLD, RS 2025-02-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219488-001 CTEXLI 250MG TABLET / ORAL RLD, RS 2025-02-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N219488-001 CTEXLI 250MG TABLET / ORAL RLD, RS 2025-02-21 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219488-001 CTEXLI 250MG TABLET / ORAL RLD, RS 2025-02-21 fd3edfee7708…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219488-001 CTEXLI 250MG TABLET / ORAL RLD, RS 2025-02-21 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-08-18 06:07:40 2026-07 N219488-001 NP 2028-02-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219488-001 ODE-523 2032-02-21 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N219488-001 NP 2028-02-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219488-001 NP 2028-02-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N219488-001 NP 2028-02-21 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219488-001 NP 2028-02-21 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219488-001 ODE-523 2032-02-21 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join CTEXLI CHENODIOL Mirum Pharmaceuticals Inc. 015384e7-4ac5-4782-a309-e40cd1421c5b 2025-12-16 Warnings, Adverse reactions Exact identifier application applno (NDA): 219488 application number: NDA219488
Documents# Document, Submission type, Date table Document Submission type Date 84907 ORIG 2026-02-04 81310 ORIG 2025-02-21 81309 ORIG 2025-02-21